Jia‐Horng Kao

42.9k total citations · 6 hit papers
613 papers, 23.5k citations indexed

About

Jia‐Horng Kao is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jia‐Horng Kao has authored 613 papers receiving a total of 23.5k indexed citations (citations by other indexed papers that have themselves been cited), including 536 papers in Epidemiology, 535 papers in Hepatology and 52 papers in Infectious Diseases. Recurrent topics in Jia‐Horng Kao's work include Hepatitis C virus research (482 papers), Liver Disease Diagnosis and Treatment (438 papers) and Hepatitis B Virus Studies (430 papers). Jia‐Horng Kao is often cited by papers focused on Hepatitis C virus research (482 papers), Liver Disease Diagnosis and Treatment (438 papers) and Hepatitis B Virus Studies (430 papers). Jia‐Horng Kao collaborates with scholars based in Taiwan, United States and China. Jia‐Horng Kao's co-authors include Ding‐Shinn Chen, Pei‐Jer Chen, Chun‐Jen Liu, Ming–Yang Lai, Chih‐Lin Lin, Tai‐Chung Tseng, Chen‐Hua Liu, Tung‐Hung Su, Hung‐Chih Yang and Yun‐Fan Liaw and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Jia‐Horng Kao

597 papers receiving 22.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

2012 834 citations Jia‐Horng Kao, Henry Lik‐Yuen Chan et al. profile →
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

2000 784 citations Jia‐Horng Kao, Pei‐Jer Chen et al. Gastroenterology profile →
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

2008 742 citations Jia‐Horng Kao, Kwang‐Hyub Han et al. profile →
Global control of hepatitis B virus infection

2002 650 citations Jia‐Horng Kao, Ding‐Shinn Chen profile →
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

2012 415 citations Tai‐Chung Tseng, Chun‐Jen Liu et al. Gastroenterology profile →
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

2020 341 citations Grace Lai–Hung Wong, Jia‐Horng Kao et al. profile →

Peers

Countries citing papers authored by Jia‐Horng Kao

Since Specialization

Citations

This map shows the geographic impact of Jia‐Horng Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia‐Horng Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia‐Horng Kao more than expected).

Fields of papers citing papers by Jia‐Horng Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia‐Horng Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia‐Horng Kao. The network helps show where Jia‐Horng Kao may publish in the future.

Co-authorship network of co-authors of Jia‐Horng Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Jia‐Horng Kao. A scholar is included among the top collaborators of Jia‐Horng Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia‐Horng Kao. Jia‐Horng Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases 2025 ·Journal of the Formosan Medical Association ·Tai‐Chung Tseng, Yao‐Chun Hsu, Tung‐Hung Su, Chen‐Hua Liu, Chia‐Chi Wang, Chih‐Lin Lin, Hwai‐I Yang, (unknown), Sheng‐Shun Yang, Cheng‐Yuan Peng, Tsung‐Hui Hu, Jee‐Fu Huang, Jia‐Horng Kao	0
2	High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease 2025 ·Clinical and Molecular Hepatology ·Tung‐Hung Su, Sheng‐Shun Yang, Mei–Hsuan Lee, Wei‐Yu Kao, Shang‐Chin Huang, (unknown), (unknown), Lung‐Wen Tsai, (unknown), Lin Che, Weichung Wang, (unknown), Jia‐Horng Kao	1
3	Serological responses to COVID-19 vaccination in patients with chronic liver diseases 2024 ·Journal of the Formosan Medical Association ·Yu‐Shan Huang, Szu‐Min Hsieh, Feng‐Chiao Tsai, Chien‐Chih Tung, Hung‐Chih Yang, Sui‐Yuan Chang, Jann‐Tay Wang, Chun‐Jen Liu, Tung‐Hung Su, Jia‐Horng Kao	1
4	Telemedicine facilitates medical care for hospitalized patients in quarantine 2024 ·Journal of the Formosan Medical Association ·Tung‐Hung Su, (unknown), Jiawei Li, Wang-Da Liu, (unknown), Chi‐Sheng Hung, Cheng‐Fu Chou, Jann‐Tay Wang, Yi‐Lwun Ho, Jia‐Horng Kao	0
5	Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease 2023 ·JHEP Reports ·Yu‐Ming Cheng, Tsung‐Han Hsieh, Chia‐Chi Wang, Jia‐Horng Kao	8
6	Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels 2023 ·Gastroenterology ·Tai‐Chung Tseng, (unknown), Chun‐Jen Liu, Chun‐Ming Hong, Tung‐Hung Su, Hung‐Chih Yang, Wanting Yang, Chen‐Hua Liu, Pei‐Jer Chen, Jia‐Horng Kao	13
7	Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease 2023 ·Journal of the Formosan Medical Association ·(unknown), Shaowen Wang, Yu‐Ming Cheng, Tsung‐Han Hsieh, Chia‐Chi Wang, Jia‐Horng Kao	10
8	HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative 2023 ·JHEP Reports ·Tai‐Chung Tseng, Tetsuya Hosaka, Chun‐Jen Liu, Fumitaka Suzuki, (unknown), Chun‐Ming Hong, Hiromitsu Kumada, (unknown), Tung‐Hung Su, Hung‐Chih Yang, Chen‐Hua Liu, Pei‐Jer Chen, Jia‐Horng Kao	5
9	Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data 2022 ·Alimentary Pharmacology & Therapeutics ·Young‐Suk Lim, Wai‐Kay Seto, Masayuki Kurosaki, Scott Fung, Jia‐Horng Kao, Jinlin Hou, Stuart C. Gordon, John F. Flaherty, Leland J. Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico	19
10	Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy 2021 ·Journal of Viral Hepatitis ·Chen‐Hua Liu, Hsin‐Yun Sun, Szu‐Min Hsieh, Wen‐Chun Liu, (unknown), Chun‐Jen Liu, Tung‐Hung Su, Tai‐Chung Tseng, Pei‐Jer Chen, Chien‐Ching Hung, Jia‐Horng Kao	6
11	Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan 2021 ·Viruses ·Chun‐Ming Hong, (unknown), Chun‐Jen Liu, (unknown), Shiou‐Hwei Yeh, Hung‐Chih Yang, Jia‐Horng Kao, Shih–Jer Hsu, Yi‐Hsiang Huang, Sheng‐Shun Yang, Hsing‐Tao Kuo, Pin‐Nan Cheng, Ming‐Lung Yu, Pei‐Jer Chen	1
12	Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma 2020 ·JNCI Cancer Spectrum ·Chi‐Ling Chen, (unknown), Amy Ming‐Fang Yen, Wei‐Shiung Yang, Jia‐Horng Kao, Pei‐Jer Chen, Chien‐Jen Chen	19
13	Modelling NAFLD disease burden in four Asian regions—2019‐2030 2020 ·Alimentary Pharmacology & Therapeutics ·Chris Estes, Henry Lik‐Yuen Chan, Rong‐Nan Chien, Wan‐Long Chuang, James Fung, George Boon‐Bee Goh, (unknown), Jee‐Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia‐Horng Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace Lai–Hung Wong, Vincent Wai‐Sun Wong, Homie Razavi	103
14	One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosis 2018 ·PLoS ONE ·(unknown), Jin‐Chuan Sheu, Yu‐Chiao Chi, Chi‐Ling Chen, Jia‐Horng Kao, Wei‐Shiung Yang	10
15	Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection 2018 ·Journal of Viral Hepatitis ·Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang‐Hyub Han, Sang Hoon Ahn, Young‐Suk Lim, Wan‐Long Chuang, Jia‐Horng Kao, Kinh Van Nguyen, Ching‐Lung Lai, Henry Lik‐Yuen Chan, Lai Wei	14
16	The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C 2017 ·Liver International ·Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang‐Hyub Han, Sang Hoon Ahn, Young‐Suk Lim, Wan‐Long Chuang, Jia‐Horng Kao, (unknown), Ching‐Lung Lai, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Lai Wei	18
17	A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection 2016 ·Liver International ·Jia‐Horng Kao, Rong‐Nan Chien, Ting‐Tsung Chang, Cheng‐Yuan Peng, Tsung‐Hui Hu, Gin‐Ho Lo, Horng‐Yuan Wang, (unknown), Jenny C. Yang, Steven Knox, Lingling Han, Hongmei Mo, Anita Mathias, Diana M. Brainard, I‐Shyan Sheen, Yu‐Chun Hsu, Chi‐Jen Chu, Wan‐Long Chuang	22
18	Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus 2016 ·Journal of Gastroenterology and Hepatology ·Wan‐Long Chuang, Rong‐Nan Chien, Cheng‐Yuan Peng, Ting‐Tsung Chang, Gin‐Ho Lo, I‐Shyan Sheen, Horng‐Yuan Wang, (unknown), Jenny C. Yang, Steven Knox, Bing Gao, Kimberly L. Garrison, Hongmei Mo, Phillip S. Pang, Yu‐Chun Hsu, Tsung‐Hui Hu, Chi‐Jen Chu, Jia‐Horng Kao	22
19	Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping 2015 ·Journal of Clinical Microbiology ·Chen‐Hua Liu, Cheng‐Chao Liang, Chun‐Jen Liu, Chih‐Lin Lin, Tung‐Hung Su, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao	59
20	Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers 2014 ·Gut ·Tai‐Chung Tseng, Chun‐Jen Liu, Hung‐Chih Yang, Chi‐Ling Chen, Wanting Yang, (unknown), Stephanie Fang–Tzu Kuo, (unknown), Tung‐Hung Su, Chia‐Chi Wang, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact